Intervention |
Control |
Outcome measures |
Findings |
Quality |
score |
• Primary outcome MTP pain ( VAS )
• Outcomes assessed
• Lower extremity function ( RB , TADL , 50 ft walk time )
|
• Significant improvement ( p o 0.05 ) in normal and fast walking velocity and stride length for intervention group at follow-up . No significant observed in control group at follow-up . |
||||||
Chalmers et al . [ 19 ] |
28 RA ( 75 %) |
• Total sample
• Age : 60 ( 10 )
• Disease duration : 15 ( 9 )
|
12 • Extra-depth footwear
• ( P . W . Minor or Drew Co ) Firm heel counter , heel height1.5 – 2.0 cm , instep lacing , wide deep toe box , thick composite sole
• Extra-depth footwear + soft orthoses
• Firm heel counter , heel height1.5 – 2.0 cm , instep lacing , wide deep toe box , thick composite sole
• Soft orthoses ; 6mm Plastazote with medium density 6mm Plastazoe metatarsal lifts
• Extra-depth footwear + semi-rigid orthoses
• Semi-rigid orthoses ; NWB cast , 3mm
|
• Primary outcome
MTP pain ( VAS )
• Outcomes assessed
• Lower extremity function ( RB , TADL , 50 ft walk time )
|
Between group measures :
• Significant improvement in MTP pain scores ( p ¼ 0.006 ) for footwear and semi-rigid orthoses group , compared to footwear and soft orthoses group and footwear alone .
• No significant differences in RB , TADL and 50ft walk time between groups .
Within group measures :
• Significant improvement in MTP pain scores ( p ¼ 0.0004 ) for footwear with semi-rigid orthoses at follow-up . No significant differences in MTP pain with footwear and Plastazote and footwear only groups at follow-up .
|
79 % |
|
Subortholen , RF and FF Nickleplast posting ,
FF 3mm PPT foam , full length leather top cover
|
• No significant differences in RB , TADL , and 50ft walk time and joint count within groups . |
||||||
Williams et al . [ 13 ] |
• 40 RA ( 73 %)
• 40 Controls ( 53 %)
|
• Total sample
• Age : not reported
• Disease duration : 17 ( 10 )
|
12 • New therapeutic footwear
• Front of shoe , heel and sole unit , leather and lining , ease of don / doff , heel height , sole thickness
• Firm contoured insole
|
• Traditional therapeutic footwear
• Soft , flat 6mm Plastazote , 3mm Poron insole
|
• Primary outcomes
• Foot pain , disability , activity limitation ( FFI )
• Foot pain , foot function , physical activity ( FHSQ )
|
Between group measures
• Significant improvement in FFI foot pain ( p ¼ 0.02 ), disability ( p ¼ 0.01 ), limitation ( p ¼ 0.02 ) and total scores ( p ¼ 0.01 ) for intervention group compared to control group at follow-up .
|
71 % |
• Significant improvement |
|||||||
In FHSQ foot pain ( p ¼ 0.00 ) and foot function ( p ¼ 0.00 ) for intervention group compared to control group at followup . |